Mifong Tam Selected Research

Reticulocytosis

1/2014	Plasmodium products contribute to severe malarial anemia by inhibiting erythropoietin-induced proliferation of erythroid precursors.
2/2009	STAT6-mediated suppression of erythropoiesis in an experimental model of malarial anemia.
2/2004	Modulation of the course and outcome of blood-stage malaria by erythropoietin-induced reticulocytosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mifong Tam Research Topics

Disease

11	Infections 10/2017 - 11/2002
10	Malaria 01/2020 - 02/2004
6	Anemia 01/2020 - 02/2004
3	Cerebral Malaria 01/2020 - 11/2010
3	Reticulocytosis 01/2014 - 02/2004
2	Parasitemia 02/2009 - 03/2007
1	Hypersensitivity (Allergy) 01/2022
1	Persistent Infection 01/2022
1	Nematode Infections 10/2017
1	Ulcerative Colitis 01/2017
1	Splenomegaly 01/2017
1	Iron Overload 01/2017
1	Cystinosis 01/2016
1	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2016
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2014
1	Neuroinflammatory Diseases 01/2013
1	Sepsis (Septicemia) 11/2010
1	Inflammation (Inflammations) 11/2010
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 08/2007
1	Hemolytic Anemia 07/2007
1	Pyruvate Kinase Deficiency of Red Cells 07/2007
1	Body Weight (Weight, Body) 11/2006
1	Cystic Fibrosis (Mucoviscidosis) 11/2002
1	Pseudomonas Infections 11/2002
1	Necrosis 11/2002

Drug/Important Bio-Agent (IBA)

4	CytokinesIBA 02/2009 - 11/2002
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 03/2007
3	pantetheinase (pantetheine hydrolase)IBA 01/2016 - 03/2007
3	Erythropoietin FDA Link 01/2014 - 02/2004
3	Interleukin-12 (IL 12)IBA 08/2007 - 01/2006
2	AntigensIBA 01/2022 - 12/2014
2	Hemoglobins (Hemoglobin)IBA 01/2020 - 11/2019
2	hemozoinIBA 11/2019 - 01/2014
2	Pyruvate KinaseIBA 01/2017 - 03/2007
2	Cysteamine (Mercaptamine)FDA Link 01/2016 - 08/2010
2	EnzymesIBA 01/2016 - 07/2007
2	Interleukin-4 (Interleukin 4)IBA 02/2009 - 05/2006
1	VaccinesIBA 01/2022
1	Oxyhemoglobins (Oxyhemoglobin)IBA 01/2020
1	Bisphosphoglycerate Mutase (Diphosphoglycerate Mutase)IBA 01/2020
1	Heme (Haem)IBA 11/2019
1	interferon regulatory factor-8 (interferon consensus sequence binding protein)IBA 10/2017
1	catechol (pyrocatechol)IBA 01/2017
1	Pharmaceutical PreparationsIBA 01/2017
1	IronIBA 01/2017
1	HydrogelsIBA 01/2017
1	ChitosanIBA 01/2017
1	Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA 10/2016
1	Drug CombinationsIBA 01/2016
1	artemisinin (artemisinine)IBA 01/2016
1	Artemether FDA Link 01/2016
1	Sulfhydryl Compounds (Thiols)IBA 01/2016
1	ArtesunateIBA 01/2016
1	ArtemisininsIBA 01/2016
1	artemotil (arteether)IBA 01/2016
1	LigandsIBA 12/2014
1	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2014
1	ChromatinIBA 01/2013
1	RNA (Ribonucleic Acid)IBA 01/2013
1	Caspase 12IBA 11/2010
1	NF-kappa B (NF-kB)IBA 11/2010
1	CaspasesIBA 11/2010
1	InflammasomesIBA 11/2010
1	Monoclonal AntibodiesIBA 02/2009
1	InterferonsIBA 02/2009
1	Interferon-gamma (Interferon, gamma)IBA 02/2009
1	Erythropoietin Receptors (Erythropoietin Receptor)IBA 02/2009
1	Interleukin-12 Subunit p40IBA 08/2007
1	Protein Isoforms (Isoforms)IBA 08/2007
1	Messenger RNA (mRNA)IBA 03/2007
1	CystamineIBA 03/2007
1	CPG-oligonucleotideIBA 11/2006
1	ThiamphenicolIBA 11/2006
1	Transcription Factors (Transcription Factor)IBA 05/2006
1	Immunoglobulins (Immunoglobulin)IBA 05/2006
1	5-(6)-carboxyfluorescein diacetate succinimidyl ester (CFSE)IBA 01/2006
1	Coloring Agents (Dyes)IBA 01/2006
1	Transferrin Receptors (Transferrin Receptor)IBA 05/2004
1	Neutralizing AntibodiesIBA 02/2004
1	InterleukinsIBA 11/2002
1	Interleukin-10 (Interleukin 10)IBA 11/2002
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2002

Therapy/Procedure

2	Therapeutics 01/2016 - 12/2014